<DOC>
	<DOC>NCT00440531</DOC>
	<brief_summary>The purpose of this trial is to determine if there is an improvement in the immune response of older adults over 50 years of age using a modified process hepatitis B vaccine and a currently licensed hepatitis B vaccine (RECOMBIVAX HB™).</brief_summary>
	<brief_title>Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male and female older adults greater than or equal to 50 years of age Any adult with a history of previous hepatitis B infection A history of vaccination with any hepatitis B vaccine Recent (&lt;72 hours) history of febrile illness (oral temperature =37.8ºC/=100.0ºF) Known or suspected hypersensitivity to any component of RECOMBIVAX HB™ or ENGERIXB™ (e.g., aluminum, yeast) Recent administration (within 3 months prior to first injection with the study vaccine) of hepatitis B immune globulin (HBIG), serum immune globulin, or any other bloodderived product Receipt of licensed inactivated vaccines within 14 days prior to first injection with the study vaccine Receipt of licensed live virus vaccines within the 30 days prior to injection with the study vaccine Receipt of investigational drugs or other investigational vaccines within 3 months prior to first injection with the study vaccine Known or suspected impairment of immunologic function or recent use of immunomodulatory medications (e.g., systemic corticosteroids). Does not include topical and inhaled steroids Pregnant women, nursing mothers, and women planning to become pregnant within the study period Any condition that, in the opinion of the investigator, might interfere with the evaluation of the study objectives</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>